Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients: The younger, the better
Saved in:
Main Authors: | Lan Zhu, Lei Zhang, Wenjun Shang, Wenhua Liu, Rula Sa, Zhiliang Guo, Longshan Liu, Jinghong Tan, Hengxi Zhang, Yonghua Feng, Wenyu Zhao, Wenqi Cong, Jianyong Wu, Changxi Wang, Gang Chen, Sihan Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2025-01-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003357 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti T-lymphocyte Globulin (Grafalon®) Use during Rabbit Anti-thymocyte Globulin (Thymoglobulin®) Shortage – A Single-center Experience
by: Shailendra Tiwari, et al.
Published: (2024-12-01) -
Absence of Rejection in a Facial Allograft Recipient with a Positive Flow Crossmatch 24 Months after Induction with Rabbit Anti-Thymocyte Globulin and Anti-CD20 Monoclonal Antibody
by: Bruce E. Gelb, et al.
Published: (2018-01-01) -
Impact of Organ Donor Pretreatment With Anti-Thymocyte Globulin in a Murine Model of Allogenic Kidney Transplantation
by: An He, et al.
Published: (2025-01-01) -
Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient
by: Heinrike Wilkens, et al.
Published: (2016-01-01) -
Fatal Epstein-Barr Virus Reactivation in an Acquired Aplastic Anemia Patient Treated with Rabbit Antithymocyte Globulin and Cyclosporine A
by: Tohru Takahashi, et al.
Published: (2015-01-01)